Clinical Trial Update: Chemoreflex Control of Sympathetic Activity in Patients With Coronary Artery Disease [NA]

View source ↗

Summary

A clinical trial update from the University of Sao Paulo General Hospital examines chemoreflex control of sympathetic activity in patients with coronary artery …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Obstructive Sleep Apnea

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Coronary Artery Disease (CAD), Obstructive Sleep Apnea (OSA) | NA | Status: UNKNOWN